Aarvik Therapeutics
Hayward, California, United States · Biotechnology, Healthcare, Health Care
Aarvik Therapeutics is pursuing exciting, novel molecules with an improved therapeutic index for several oncology targets by combining a novel modular antibody platform with multiple target mechanisms.
Key facts
- Headquarters
- Hayward, California, United States
- Employees
- 10
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Private
- Website
- aarviktx.com
- Company page
Recent activity at Aarvik Therapeutics
- : Aarvik Therapeutics has secured a successful Series Seed 2 financing round. This funding will help advance the company's proprietary MUTTA™ platform and reach targeted research milestones.
- : Aarvik Therapeutics
- : Aarvik Therapeutics announces collaboration option exercise by ArriVent BioPharma
- : Aarvik Therapeutics, Inc.
Aarvik Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2025 | Seed | Undisclosed |
| Dec 2024 | Seed | $1.2M |
| Sep 2021 | Venture | $8.3M |
Leadership
- Jagath Reddy Junutula, Director
- Pradeep Fernandes, Chief Operating Officer
- Jagath Reddy Junutula, Founder
- Pradeep Fernandes, Chief Operating Officer
Verified email and direct lines for Aarvik Therapeutics’s decision-makers are on Fundz. See plans
Employee benefit plans
Aarvik Therapeutics files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Aarvik Therapeutics in the news
Companies similar to Aarvik Therapeutics
- BioLineRx Ltd · Biotechnology, Healthcare, Health Care, research, Therapeutics
- Onward Therapeutics SA · Biotechnology, Health Care, research, Therapeutics
- Cocrystal Pharma, Inc. · Biotechnology, Healthcare, Health Care, Therapeutics
- Swarm Oncology Ltd · Biotechnology, Health Care, research, Therapeutics
- Os Therapies · Biotechnology, Healthcare, Health Care, Therapeutics
About Aarvik Therapeutics: questions and answers
What does Aarvik Therapeutics do?
Aarvik Therapeutics is pursuing exciting, novel molecules with an improved therapeutic index for several oncology targets by combining a novel modular antibody platform with multiple target mechanisms.
Where is Aarvik Therapeutics headquartered?
Aarvik Therapeutics is headquartered in Hayward, California, United States.
How many employees does Aarvik Therapeutics have?
Aarvik Therapeutics has about 10 employees.
Has Aarvik Therapeutics raised funding?
Yes. Fundz has recorded 3 funding events for Aarvik Therapeutics. The most recent, Seed of Undisclosed, was in Sep 2025.
Who leads Aarvik Therapeutics?
Jagath Reddy Junutula is a Founder at Aarvik Therapeutics.
What is the latest news on Aarvik Therapeutics?
On Sep 29, 2025, Aarvik Therapeutics has secured a successful Series Seed 2 financing round. This funding will help advance the company's proprietary MUTTA™ platform and reach targeted research milestones.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy